DVA Increases GP Payments for Veterans’ Claims Work
12 Feb 2026
At the same time, doctors can expect closer monitoring of their claims work to prevent fraud.
The changes, effective 9 February, mean a “substantial increase” in payments for services like short and long consultations, completing medical forms, and preparing clinical notes. For example, a short consultation (under 20 minutes) has increased from $37.10 to $49.90, while a long consultation (over 40 minutes) has gone from $105.10 to $141.35. Fees for completing DVA medical reports, impairment assessments, diagnostic reports, and rehabilitation forms have also risen from $14.70 to $22.55.
Veterans’ Affairs Minister Matt Keogh said the new payments better reflect the time and expertise required, while also matching rates in other jurisdictions. He added the Government is investing over $203 million to strengthen monitoring and compliance, targeting fraudulent providers. Where billing issues are found, payments may be delayed, held, or refused.
In 2024–25, the DVA received 43,727 requests for medical reports related to liability and compensation claims. Minister Keogh stressed that most GPs act ethically, but a small number of providers or advocates try to exploit the system. The Government is also reviewing protections for veterans using advocacy services.
RACGP Rural Chair Associate Professor Michael Clements, a veteran, welcomed the fee increase, calling it “reasonable and appropriate” and recognising the expertise required to complete reports. He noted that the new guidance also includes stronger wording around enforcement, with DVA able to investigate and withhold payment where concerns arise.
Minister Keogh said the reforms form part of a $739.2 million investment to improve veteran care, focusing on early intervention, prevention, and better access to treatment and rehabilitation. Accepted service-related conditions allow veterans to access modern, evidence-based care, including medicinal cannabis and innovative treatments like MDMA for PTSD and psilocybin for treatment-resistant depression, all with clinical safeguards.
Source: Department of Veterans’ Affairs / RACGP / newsGP
